A nomogram for predicting progress-free survival in primary extramedullary multiple myeloma using routine laboratory variables [0.03%]
基于实验室常规检测指标的原发性髓外多发性骨髓瘤无进展生存预测列线图
Yating Li,Jie Chen,Yunqi Cui et al.
Yating Li et al.
Objectives: Extramedullary involvement in multiple myeloma (MM) represents aggressive disease, with clinical stratification of primary extramedullary disease (EMD) remaining a challenge. In this study, we aimed to develop...
Ine Schmale
Ine Schmale
The treatment of multiple myeloma developed remarkably improved over the last decade. Still there is a medical need for efficient and safe therapies. This year's congress of the European Hematology Association (EHA) provided insights to upc...
Real-World Insights into Avatrombopag's Effectiveness and Safety in Adults with Primary Immune Thrombocytopenia: A Retrospective Analysis from Central and Eastern Europe [0.03%]
阿伐曲波帕对成人原发性免疫性血小板减少症疗效和安全性的现实世界研究：来自中欧和东欧的回顾性分析
Barbara Skopec,Dražen Pulanić,Libor Červinek
Barbara Skopec
Introduction: Primary immune thrombocytopenia (ITP) is an autoimmune condition marked by low platelet counts, leading to symptoms such as bleeding. Avatrombopag (AVA), a second-generation thrombopoietin receptor agonist (...
Artificial intelligence in hematopoietic stem cell transplantation care and complication management [0.03%]
人工智能在造血干细胞移植护理和并发症管理中的应用
Amin T Turki,Alberto Mussetti,Katja Marie Scheidler et al.
Amin T Turki et al.
The practice of allogeneic hematopoietic stem cell transplantation (alloHCT) has evolved from an experimental therapy with high mortality rates to a routine treatment that is increasingly performed worldwide. Parallel to this expansion, tra...
Approach to hairy-cell leukemia in the new therapeutic era with special emphasis on age and comorbidities [0.03%]
重视年龄和合并症的新治疗时代的毛细胞白血病治疗方法
Ilana Levy Yurkovski,Tamar Tadmor
Ilana Levy Yurkovski
Hairy-cell leukemia (HCL) is a rare chronic hematologic malignancy, generally presenting with pancytopenia, relative lymphocytosis, monocytopenia, and splenomegaly. Diagnosis is based on typical bone marrow evaluation with the BRAF-V600E mu...
Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I [0.03%]
先天性红系无效生成性贫血I型患者血栓事件发生率增加
Mahdi Asleh,Aya Khalaila,Yotam Eshel et al.
Mahdi Asleh et al.
Background: Congenital Dyserythropoietic Anemia Type I (CDA-I) is a rare disorder of erythropoiesis. All CDA-I patients are expected to have iron overload and chronic hemolysis. Patients with severe anemia may undergo spl...
Jayastu Senapati,Nicholas J Short
Jayastu Senapati
Editorial
Acta haematologica. 2025 Jul 29:1-5. DOI:10.1159/000547659 2025
Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia [0.03%]
异基因干细胞移植在急性淋巴细胞白血病中的发展方向
Natalie Rafaeli,Partow Kebriaei
Natalie Rafaeli
Background Allogeneic stem cell transplantation (ASCT) has been a cornerstone of acute lymphoblastic leukemia (ALL) treatment for decades, with significant improvements in patient survival. These advancements are linked to better therapies,...
Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological Cancer [0.03%]
超越CAR-T：CAR-NK/T细胞在血液系统恶性肿瘤中崛起
Mohammadamin Noorafrooz,Robert Peter Gale,Mohadese Dashtkoohi
Mohammadamin Noorafrooz
I get a message the abstract is missing, but it IS here!!!!! Background: Chimeric Antigen Receptor (CAR)-NK/T-cells offer a new approach in immune therapy...
Towards Clinically Actionable Machine Learning and Artificial Intelligence Algorithms in Acute Leukemia: A Systematic Narrative Review [0.03%]
急性白血病临床行动指南之机器学习和人工智能算法的系统叙述性综述
Jean Mg Sabile,Ping Zhang,Anil V Parwani et al.
Jean Mg Sabile et al.
Introduction: Acute myeloid leukemia (AML) is a heterogenous hematologic malignancy that maintains high relapse rates and poor survival despite ongoing treatment advances. There is critically unmet need for consistently p...